Germline ERBB2/HER2 Coding Variants Are Associated with Increased Risk of Myeloproliferative Neoplasms.
Cancers
Braunstein, Evan M EM; Chen, Hang H; Juarez, Felicia F; Yang, Fanghan F; Tao, Lindsay L; Makhlin, Igor I; Williams, Donna M DM; Chaturvedi, Shruti S; Pallavajjala, Aparna A; Karantanos, Theodoros T; Martin, Renan R; Wohler, Elizabeth E; Sobreira, Nara N; Gocke, Christopher D CD; Moliterno, Alison R AR
Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer.
The Prostate
Markowski, Mark C MC; Shenderov, Eugene E; Eisenberger, Mario A MA; Kachhap, Sushant S; Pardoll, Drew M DM; Denmeade, Samuel R SR; Antonarakis, Emmanuel S ES
The role of myoglobin in epithelial cancers: Insights from transcriptomics.
International Journal Of Molecular Medicine
Bicker, Anne A; Nauth, Theresa T; Gerst, Daniela D; Aboouf, Mostafa Ahmed MA; Fandrey, Joachim J; Kristiansen, Glen G; Gorr, Thomas Alexander TA; Hankeln, Thomas T
Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer.
Journal Of The National Cancer Institute
Loree, Jonathan M JM; Bailey, Ann M AM; Johnson, Amber M AM; Yu, Yao Y; Wu, Wenhui W; Bristow, Christopher A CA; Davis, Jennifer S JS; Shaw, Kenna R KR; Broaddus, Russell R; Banks, Kimberly C KC; Lanman, Richard B RB; Meric-Bernstam, Funda F; Overman, Michael J MJ; Kopetz, Scott S; Raghav, Kanwal K